The stocks of companies that make or are developing the new class of weight-loss and diabetes-management drugs were sharply ...

Over the past year, the question has been coming in from everywhere – from my patients and family members, from colleagues ...

Global diabetes rates have surged, particularly in low-resource areas, revealing critical gaps in treatment access and ...